Skip to search formSkip to main contentSkip to account menu

rizatriptan

Known as: rizatriptan [Chemical/Ingredient], Rizatriptán, N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine 
National Institutes of Health

Related topics

Related topics

13 relations
Angina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Drug AllergyRizatriptan Sulfate

Narrower (4)

MK 0462Rizatriptan benzoaterizatriptan 10 MG Disintegrating Oral Tabletrizatriptan 10 MG Oral Tablet

Broader (3)

Serotonin AgonistsTriazolesTryptamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study
Objective.— To evaluate the pharmacokinetic profile and tolerability of single doses of rizatriptan oral disintegrating tablets… 
Review
2011
Review
2011
Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine
(Headache 2011;51:118‐123) 
Review
2007
Review
2007
Rizatriptan for acute migraine.
BACKGROUND There are a number of different drug treatments for acute migraine, including currently four triptans, with several… 
Review
2007
Review
2007
Acute treatment of paediatric migraine: A meta‐analysis of efficacy
Aim:  To undertake a meta‐analysis of all randomised controlled trials (RCTs) on the acute pharmacologic treatment of children… 
2007
2007
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans
Background:  In the clinical trial setting, oral rizatriptan 10 mg has greater efficacy than other oral triptans in freedom from… 
2006
2006
Determination of rizatriptan in human plasma by liquid chromatographic-eletrospray tandem mass spectrometry: application to a pharmacokinetic study.
A sensitive liquid chromatographic-tandem mass spectrometry(LC-MS/MS) method was developed for the determination of rizatriptan… 
Review
2003
Review
2003
Triptans for treatment of acute pediatric migraine: a systematic literature review.
2002
2002
Restoring Migraine Sufferers’ Ability to Function Normally: A Comparison of Rizatriptan and Other Triptans in Randomized Trials
Background: Many migraine patients are unable to function normally during a migraine attack. Assessments of treatment efficacy… 
Review
2001
Review
2001
Comparative aspects of triptans in treating migraine.
1996
1996
The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in…
MK-0462 (rizatriptan) is a 5HT1D agonist being developed for the treatment of migraine. The assay for this substance in plasma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)